Neumora Therapeutics, Inc. (NMRA) Tops Q3 EPS by 10c
Tweet
Share
E-mailGet Alerts NMRA Hot Sheet
Join SI Premium – FREE
Neumora Therapeutics, Inc. (NASDAQ: NMRA) reported Q3 EPS of ($0.35), $0.10 better than the analyst estimate of ($0.45).
For earnings history and earnings-related data on Neumora Therapeutics, Inc. (NMRA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blue Owl leads $2.4 billion debt deal for Iren data center
- Trilogy Metals signs $35.6M investment deal with U.S. Dept. of War
- Electra Therapeutics files for proposed IPO
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
